Blood Glucose Monitoring Systems - Global Market Outlook (2019-2027)

   |      |      |  

Blood Glucose Monitoring Systems - Global Market Outlook (2019-2027)

"The Global Blood Glucose Monitoring Systems Market is accounted for $9.45 billion in 2019 and is expected to reach $15.41 billion by 2027 growing at a CAGR of 6.3% during the forecast period. Increasing number of product launches and increasing prevalence of diabetes are the major factors propelling the market growth. However, factors such as strict regulations and decreased lab investments are hampering the market growth.

Blood glucose monitoring systems are diagnostics systems that are very essential for the care and treatment of diabetes, it is used to measure and monitor the levels of blood sugar in the patients. The significance of blood glucose monitoring system’s command is very high, with the growing prevalence of diabetes and diabetic population across the regions. These systems usually take blood samples, but with rising innovation and advancements in technology, even blood testing is considered traditional and sensors are deployed for continuous monitoring.

Based on the patient care setting, the self/home care segment is going to have a huge demand owing to rising diabetic population, and increasing consciousness about regular monitoring of glucose levels and increasing product launches enhancing patient comfort when used at home. By geography, North America is estimated to have a lucrative growth in the forecast period. The growth is mainly attributed by growing prevalence of diabetes in the US and Canada, favorable reimbursements, awareness programs.

Some of the key players profiled in the Blood Glucose Monitoring Systems Market include Abbott, Ascensia Diabetes Care Holdings AG, Braun Melsungen AG, Dexcom, Inc., DiamonTech GmbH, Hoffmann-La Roche Ltd., Lifescan Inc., Medtronic, Terumo Medical Corporation, Ypsomed, Nipro, Sanofi, Arkray, Acon Laboratories and Prodigy Diabetes Care.

Types Covered:
• Non-Invasive
• Invasive

Modalities Covered:
• Non- Wearable
• Wearable

Distribution Channels Covered:
• Retail Sales
• Institutional Sales

Devices Covered:
• Self-monitoring of Blood Glucose Monitoring Systems
• Continuous Blood Glucose Monitoring Systems

Testing Sites Covered:
• Alternate Site Testing
• Fingertip testing

Patient Care Settings Covered:
• Hospital & Clinics
• Self/Home Care

Applications Covered:
• Gestational Diabetes
• Diabetes

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o UK
o Italy
o France
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o South Korea
o Rest of Asia Pacific
• South America
o Argentina
o Brazil
o Chile
o Rest of South America
• Middle East & Africa
o Saudi Arabia
o UAE
o Qatar
o South Africa
o Rest of Middle East & Africa

What our report offers:
- Market share assessments for the regional and country-level segments
- Strategic recommendations for the new entrants
- Covers Market data for the years 2018, 2019, 2020, 2024 and 2027
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

Free Customization Offerings:
All the customers of this report will be entitled to receive one of the following free customization options:
• Company Profiling
o Comprehensive profiling of additional market players (up to 3)
o SWOT Analysis of key players (up to 3)
• Regional Segmentation
o Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
• Competitive Benchmarking
Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances
"

"1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Emerging Markets
3.8 Impact of Covid-19

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Blood Glucose Monitoring Systems Market, By Type
5.1 Introduction
5.2 Non-Invasive
5.3 Invasive

6 Global Blood Glucose Monitoring Systems Market, By Modality
6.1 Introduction
6.2 Non- Wearable
6.3 Wearable

7 Global Blood Glucose Monitoring Systems Market, By Distribution Channel
7.1 Introduction
7.2 Retail Sales
7.3 Institutional Sales

8 Global Blood Glucose Monitoring Systems Market, By Device
8.1 Introduction
8.2 Self-monitoring of Blood Glucose Monitoring Systems
8.2.1 Blood Glucose meters
8.2.2 Lancets & Lancing Devices
8.2.3 Testing strips
8.3 Continuous Blood Glucose Monitoring Systems
8.3.1 Receivers
8.3.2 Sensors
8.3.3 Transmitters

9 Global Blood Glucose Monitoring Systems Market, By Testing Site
9.1 Introduction
9.2 Alternate Site Testing
9.3 Fingertip testing

10 Global Blood Glucose Monitoring Systems Market, By Patient Care Setting
10.1 Introduction
10.2 Hospital & Clinics
10.3 Self\/Home Care

11 Global Blood Glucose Monitoring Systems Market, By Application
11.1 Introduction
11.2 Gestational Diabetes
11.3 Diabetes
11.3.1 Type 1 Diabetes
11.3.2 Type 2 Diabetes

12 Global Blood Glucose Monitoring Systems Market, By Geography
12.1 Introduction
12.2 North America
12.2.1 US
12.2.2 Canada
12.2.3 Mexico
12.3 Europe
12.3.1 Germany
12.3.2 UK
12.3.3 Italy
12.3.4 France
12.3.5 Spain
12.3.6 Rest of Europe
12.4 Asia Pacific
12.4.1 Japan
12.4.2 China
12.4.3 India
12.4.4 Australia
12.4.5 New Zealand
12.4.6 South Korea
12.4.7 Rest of Asia Pacific
12.5 South America
12.5.1 Argentina
12.5.2 Brazil
12.5.3 Chile
12.5.4 Rest of South America
12.6 Middle East & Africa
12.6.1 Saudi Arabia
12.6.2 UAE
12.6.3 Qatar
12.6.4 South Africa
12.6.5 Rest of Middle East & Africa

13 Key Developments
13.1 Agreements, Partnerships, Collaborations and Joint Ventures
13.2 Acquisitions & Mergers
13.3 New Product Launch
13.4 Expansions
13.5 Other Key Strategies

14 Company Profiling
14.1 Abbott
14.2 Ascensia Diabetes Care Holdings AG
14.3 Braun Melsungen AG
14.4 Dexcom, Inc.
14.5 DiamonTech GmbH
14.6 Hoffmann-La Roche Ltd.
14.7 Lifescan Inc.
14.8 Medtronic
14.9 Terumo Medical Corporation
14.10 Ypsomed
14.11 Nipro
14.12 Sanofi
14.13 Arkray
14.14 Acon Laboratories
14.15 Prodigy Diabetes Care

List of Tables
Table 1 Global Blood Glucose Monitoring Systems Market Outlook, By Region (2018-2027) ($MN)
Table 2 Global Blood Glucose Monitoring Systems Market Outlook, By Type (2018-2027) ($MN)
Table 3 Global Blood Glucose Monitoring Systems Market Outlook, By Non-Invasive (2018-2027) ($MN)
Table 4 Global Blood Glucose Monitoring Systems Market Outlook, By Invasive (2018-2027) ($MN)
Table 5 Global Blood Glucose Monitoring Systems Market Outlook, By Modality (2018-2027) ($MN)
Table 6 Global Blood Glucose Monitoring Systems Market Outlook, By Non- Wearable (2018-2027) ($MN)
Table 7 Global Blood Glucose Monitoring Systems Market Outlook, By Wearable (2018-2027) ($MN)
Table 8 Global Blood Glucose Monitoring Systems Market Outlook, By Distribution Channel (2018-2027) ($MN)
Table 9 Global Blood Glucose Monitoring Systems Market Outlook, By Retail Sales (2018-2027) ($MN)
Table 10 Global Blood Glucose Monitoring Systems Market Outlook, By Institutional Sales (2018-2027) ($MN)
Table 11 Global Blood Glucose Monitoring Systems Market Outlook, By Device (2018-2027) ($MN)
Table 12 Global Blood Glucose Monitoring Systems Market Outlook, By Self-monitoring of Blood Glucose Monitoring Systems (2018-2027) ($MN)
Table 13 Global Blood Glucose Monitoring Systems Market Outlook, By Blood Glucose meters (2018-2027) ($MN)
Table 14 Global Blood Glucose Monitoring Systems Market Outlook, By Lancets & Lancing Devices (2018-2027) ($MN)
Table 15 Global Blood Glucose Monitoring Systems Market Outlook, By Testing strips (2018-2027) ($MN)
Table 16 Global Blood Glucose Monitoring Systems Market Outlook, By Continuous Blood Glucose Monitoring Systems (2018-2027) ($MN)
Table 17 Global Blood Glucose Monitoring Systems Market Outlook, By Receivers (2018-2027) ($MN)
Table 18 Global Blood Glucose Monitoring Systems Market Outlook, By Sensors (2018-2027) ($MN)
Table 19 Global Blood Glucose Monitoring Systems Market Outlook, By Transmitters (2018-2027) ($MN)
Table 20 Global Blood Glucose Monitoring Systems Market Outlook, By Testing Site (2018-2027) ($MN)
Table 21 Global Blood Glucose Monitoring Systems Market Outlook, By Alternate Site Testing (2018-2027) ($MN)
Table 22 Global Blood Glucose Monitoring Systems Market Outlook, By Fingertip testing (2018-2027) ($MN)
Table 23 Global Blood Glucose Monitoring Systems Market Outlook, By Patient Care Setting (2018-2027) ($MN)
Table 24 Global Blood Glucose Monitoring Systems Market Outlook, By Hospital & Clinics (2018-2027) ($MN)
Table 25 Global Blood Glucose Monitoring Systems Market Outlook, By Self\/Home Care (2018-2027) ($MN)
Table 26 Global Blood Glucose Monitoring Systems Market Outlook, By Application (2018-2027) ($MN)
Table 27 Global Blood Glucose Monitoring Systems Market Outlook, By Gestational Diabetes (2018-2027) ($MN)
Table 28 Global Blood Glucose Monitoring Systems Market Outlook, By Diabetes (2018-2027) ($MN)
Table 29 Global Blood Glucose Monitoring Systems Market Outlook, By Type 1 Diabetes (2018-2027) ($MN)
Table 30 Global Blood Glucose Monitoring Systems Market Outlook, By Type 2 Diabetes (2018-2027) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.
"

Blood Glucose Monitoring Systems - Global Market Outlook (2019-2027)

.